Shelby N. Turner

FDA investigator

Appears on 5 documents from 2022 to 2025, mostly at sites in Texas. Most often cites testing and release for distribution (21 CFR 211.165(a)).

5
Documents on file
5.4
Observations per 483
2022
First seen
2025
Most recent

What they cite most

From 27 observations

Activity by year

2022: 1, 2023: 2, 2025: 2

Where

Texas 4 · North Carolina 1

Is Shelby N. Turner coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Pure Indulgence AestheticsDec 2, 2025 · Southlake, Texas
Amended 483 United Laboratories Manufacturing, LLCAug 15, 2025 · Carrollton, Texas
483 ARG Laboratories, IncSep 20, 2023 · Dallas, Texas
483 TAKA USA, INC. dba Cosmetic InnovationsFeb 7, 2023 · Coppell, Texas
483 Aurolife Pharma LLCAug 26, 2022 · Durham, North Carolina

About this profile

What does Shelby N. Turner inspect?

Shelby N. Turner appears on 5 documents on file covering 5 sites, mostly in Texas.

What do they cite most often?

21 CFR 211.165(a) (testing and release for distribution), followed by 21 CFR 211.22(a) and 21 CFR 211.110(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Shelby N. Turner is dated Dec 2, 2025.